A Clinical Study GK01 Cell Injection in Subjects With Advanced Lung Cancer

NCT07673419 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Lung Cancer

Interventions

DRUG: GK01 Injection

Sponsor

Beijing Geekgene Technology Co., LTD